Neurological Disorders and Imaging Physics. Volume 2 : Engineering and Clinical Perspectives of Multiple Sclerosis / edited by Ayman El-Baz and Jasjit S. Suri.

Format:

Book

Contributor:

El-Baz, Ayman, editor.

Suri, Jasjit S., editor.

Institute of Physics (Great Britain), publisher.

Series:

IOP ebooks. 2020 collection.

IOP Ebooks Series

Language:

English

Subjects (All):

Central nervous system--Diseases--Diagnosis.

Central nervous system.

Biomedical engineering.

Physical Description:

1 online resource (various pagings) : illustrations (some color).

Edition:

First edition.

Other Title:

Engineering and clinical perspectives of multiple sclerosis.

Place of Publication:

Bristol [England] (Temple Circus, Temple Way, Bristol BS1 6HG, UK) : IOP Publishing, [2020]

System Details:

Mode of access: World Wide Web.

System requirements: Adobe Acrobat Reader, EPUB reader, or Kindle reader.

Biography/History:

Ayman El-Baz is a Professor, University Scholar, and Chair of the Bioengineering Department at the University of Louisville, Kentucky. Dr. El-Baz earned his BSc and MSc degrees in electrical engineering in 1997 and 2001, respectively. He earned his PhD in electrical engineering from the University of Louisville in 2006. Dr. El-Baz has 17 years of hands-on experience in the fields of bio-imaging modeling and non-invasive computer-assisted diagnosis systems. Jasjit S. Suri is an innovator, scientist, visionary, industrialist and an internationally known world leader in biomedical engineering. Dr. Suri has spent over 25 years in the field of biomedical engineering/devices and its management. In 2018, he was awarded the Marquis Life Time Achievement Award for his outstanding contributions and dedication to medical imaging and its management.

Summary:

More than two million people were affected with multiple sclerosis (MS) worldwide in 2015 with rates varying widely in different regions and among different populations. This book explores the basics of MS, which is the most common immune-mediated disorder affecting the central nervous system. MS is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. The symptoms of MS will be covered in this book, in addition to active research topics, such as exoskeleton-assisted rehabilitation training, combinational drug therapies, characterization of balance disorders and many more related topics.

Contents:

1. Exoskeleton-assisted rehabilitation training improves cognitive and motor functions in multiple sclerosis patients

1.1. Introduction

1.2. Methods

1.3. Results

1.4. Discussion

2. The early stages of multiple sclerosis : new targets for the development of combinational drug therapies

2.1. Introduction

2.2. Evidence for the involvement of microbial triggers of MS

2.3. Blocking the bacterial triggers of MS

2.4. Immunomodulation and immunosuppressants in controlling MS

2.5. Targeting inflammatory processes to treat MS

2.6. Natural products and herbal medicines as anti-inflammatory agents

2.7. Plant based approaches : natural combination therapies

2.8. Conclusion

3. Advanced technique for characterization of balance disorders in multiple sclerosis : posturography

3.1. Introduction

3.2. Technical materials in posturography

3.3. Analysis methods in posturography

3.4. Conclusion

4. Recent developments in the understanding and assessment of hope and psycho-emotional expressions of illness for people with multiple sclerosis

4.1. Introduction

5. Multiple sclerosis symptoms

5.1. Introduction

5.2. Diagnosis of multiple sclerosis

5.3. Current classification includes

5.4. Clinical symptomatology

5.5. The incidence and prevalence of psychiatric disorders in multiple sclerosis

5.6. Conclusion

6. Using transcranial direct current stimulation to manage symptoms of multiple sclerosis

6.1. Introduction

6.2. Technical considerations for tDCS

6.3. Potential clinical applications in MS

6.4. Conclusions

7. Oxidative stress and sterile inflammation in multiple sclerosis

7.1. Introduction to the disease

7.2. Redox system

7.3. Why is a free radical dangerous?

7.4. Oxidative stress in multiple sclerosis

7.5. Dangerous crystals

7.6. Cholesterol needle-shaped crystals and sterile inflammation in MS

7.7. Monosodium urate crystals and sterile inflammation in MS

7.8. Conclusion

8. The influence of auditory neuroprosthetics on gait and postural recovery in multiple sclerosis

8.1. Introduction

8.2. Methods

8.3. Results

8.4. Discussion

9. Neuropsychological assessment in multiple sclerosis

9.1. Cognition in multiple sclerosis

9.2. Neuropsychological batteries for MS

9.3. Cognitive assessment : the relevance in clinical and research fields

9.4. Methodological issues

9.5. Variables influencing cognition

9.6. Cognitive impairment and cognitive decline

9.7. Future perspectives

10. Imaging disconnection in multiple sclerosis

10.1. The complexity of multiple sclerosis

10.2. The importance of MRI in MS

10.3. Brain organization in MS : the impact of disease on connectivity

10.4. Conclusions and future developments

11. Gait analyses in multiple sclerosis; and time series

11.1. Introduction

11.2. Determinants of gait

11.3. Kinetic and kinematics of gait

11.4. Phases of the gait cycle

11.5. Temporal-spatial features of gait

11.6. Kinetics of gait

11.7. Joint torques and forces/kinematics

11.8. The layout of the gait function in chaos AND the complexity of the gait function in order

11.9. Gait analysis methods

11.10. Gait problems and cortical involvement in multiple sclerosis : choosing the right analysis method

11.11. Conclusion

12. A brain-computer interface web browser for multiple sclerosis patients

12.1. Introduction

12.2. Background

12.3. Subject database

12.4. Methods

12.5. Results

12.6. Discussion

12.7. Conclusion

13. Language, speech and voice symptomatology (dysarthria) in multiple sclerosis : electroglottographic and acoustic analysis for assessment

13.1. Objective instrumental measurements of voice (electroglottography)

13.2. Electroglottography definition and description

13.3. Acoustic analysis of speech

13.4. Variables of electroglottographic analysis during sustained phonation

13.5. Variables of electroglottographic analysis during connected speech

13.6. Findings of perceptual, acoustic and electroglottographic variables in MS

13.7. Voice quality

13.8. Articulation and speech rate

13.9. Prosody

13.10. Summary of findings and conclusions

14. Novel approaches for segmenting cerebral vasculature

14.1. Introduction

14.2. Cerebral blood vessels segmentation

14.3. Summary.

Notes:

"Version: 20191101"--Title page verso.

Includes bibliographical references.

Title from PDF title page (viewed on December 9, 2019).

Description based on print version record.

ISBN:

9780750317627

0750317620

OCLC:

1130295077